{"id":93,"date":"2021-11-11T15:06:59","date_gmt":"2021-11-11T15:06:59","guid":{"rendered":"https:\/\/obgconnect.com\/senseclinical\/?p=93"},"modified":"2021-11-12T19:11:20","modified_gmt":"2021-11-12T19:11:20","slug":"isuog-recommendations-for-preeclampsia-prevention-combined-screening-and-the-role-of-ultrasound","status":"publish","type":"post","link":"https:\/\/obgconnect.com\/senseclinical\/2021\/11\/11\/isuog-recommendations-for-preeclampsia-prevention-combined-screening-and-the-role-of-ultrasound\/","title":{"rendered":"ISUOG Recommendations for Preeclampsia Prevention: Combined Screening and the Role of Ultrasound"},"content":{"rendered":"\n

SUMMARY:<\/h2>\n\n\n\n

The ISUOG Clinical Standards Committee, based on the latest evidence, has released practice guidelines that provide recommendations regarding the role of ultrasound in screening for and follow-up of preeclampsia. Preventative strategies (such as low-dose aspirin) for preeclampsia are effective if started in the first trimester and should begin as soon as high-risk status is identified.  <\/p>\n\n\n\n

Given the superiority of combined screening, the use of Doppler cut-offs as a standalone screening modality should be avoided if combined screening is available (GRADE OF RECOMMENDATION: B)<\/strong><\/p><\/blockquote>\n\n\n\n

Note: <\/strong>Screening <\/em>refers to identification of at risk cases that may lead to prevention | Prediction <\/em>refers to ability to identify at risk cases, but no evidence available regarding improved outcomes  <\/p>\n\n\n\n

Combined Screening<\/a>
Ultrasound Only<\/a>
Multifetal Pregnancies<\/a><\/p>\n\n\n\n

KEY POINTS:<\/h2>\n\n\n\n

Combined Screening (10-13 weeks) \u2013 Preferred where available   <\/h3>\n\n\n\n